Sign up for the QMED & MD+DI Daily newsletter.
Cyberonics Makes Patent-Related Moves
Looking to rebound after a year of financial scandals, neurostimulation firm Cyberonics has been active with patents lately. On Tuesday, it signed an agreement with Johnson & Johnson's Ethicon Endo-Surgery granting EES the rights to Cyberonics' patents pertaining to Vagus Nerve Stimulation related to treating obesity, as well as treating diabetes and hypertension in overweight people.
December 19, 2007
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
Cyberonics will receive $9.5 million up front and royalties on the sales of the products. Today, Cyberonics announced that it has acquired patents giving it the rights to Vagus Nerve Stimulation for treatment of stroke and traumatic brain injury. The patents were licensed from Southern Illinois University.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)